These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3529324)

  • 1. Limitations of animal models in predicting beta-lactam efficacy for endocarditis and meningitis.
    Gerberding JL; Sande MA
    Rev Infect Dis; 1986; 8 Suppl 3():S315-8. PubMed ID: 3529324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of therapy in animal models to bacterial infection in human disease.
    Tunkel AR; Scheld WM
    Infect Dis Clin North Am; 1989 Sep; 3(3):441-59. PubMed ID: 2504810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and bacteriological correlations between antimicrobial therapy of experimental meningitis in rabbits and meningitis in humans: a review.
    McCracken GH
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():97-108. PubMed ID: 6365874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
    Sande MA; Brooks-Fournier RA; Gerberding JL
    Am J Med; 1987 Apr; 82(4A):63-6. PubMed ID: 3578331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
    English AR; Girard D; Cimochowski C; Faiella J; Retsema JA; Lynch JE
    Rev Infect Dis; 1986; 8 Suppl 5():S535-42. PubMed ID: 3026002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Enterococcus endocarditis model in experimental animals and its relevance to human infection.
    Gutschik E
    J Antimicrob Chemother; 1993 May; 31 Suppl D():87-95. PubMed ID: 8335527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critique of animal models in antibiotic research.
    Barza M
    Scand J Infect Dis Suppl; 1978; (14):109-17. PubMed ID: 279963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
    Falagas ME; Matthaiou DK; Bliziotis IA
    J Antimicrob Chemother; 2006 Apr; 57(4):639-47. PubMed ID: 16501057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningitis due to Haemophilus influenzae with decreased susceptibility to beta-lactams].
    Bourdon S; Lemarié C; Perez L; Dabernat H
    Med Mal Infect; 2004 Jul; 34(7):325-7. PubMed ID: 15679238
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-lactam antibiotics active against methicillin-resistant Staphylococcus aureus.
    Moreillon P; Franciolli M; Cantoni L; Bille J; Glauser MP
    J Infect Dis; 1991 May; 163(5):1165-6. PubMed ID: 2064675
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic activity of ceftazidime and eleven other beta-lactam antibiotics against experimental Haemophilus influenzae, type b meningitis.
    McColm AA; Ryan DM
    J Antimicrob Chemother; 1984 May; 13(5):517-20. PubMed ID: 6376459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the efficacy of ciprofloxacin in animal models of infection.
    Andriole VT
    Am J Med; 1989 Nov; 87(5A):32S-34S. PubMed ID: 2589379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental endocarditis: a review of its relevance to human endocarditis.
    Carbon C
    J Antimicrob Chemother; 1993 May; 31 Suppl D():71-85. PubMed ID: 8335526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of meropenem on an experimental guinea pig model of meningitis with type b β-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae.
    Fujimoto K; Kanazawa K; Takemoto K; Urasaki K; Ueda Y; Ubukata K; Sunakawa K
    J Infect Chemother; 2013 Aug; 19(4):593-8. PubMed ID: 23203217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophilus paraphrophilus endocarditis: case report and review.
    Coll-Vinent B; Surís X; López-Soto A; Miró JM; Coca A
    Clin Infect Dis; 1995 May; 20(5):1381-3. PubMed ID: 7620027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental staphylococcal endocarditis: an overview.
    Gutschik E
    Scand J Infect Dis Suppl; 1983; 41():87-94. PubMed ID: 6589765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of quinolones in experimental animal models of infections.
    Scheld WM
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):275-90. PubMed ID: 1864288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of the experimental model of bacterial endocarditis].
    Carbon C
    Bull Acad Natl Med; 1995 Apr; 179(4):767-74; discussion 775-6. PubMed ID: 7648311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on: The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
    Baddour LM; Steckelberg JM; Wilson WR
    J Antimicrob Chemother; 2006 Jun; 57(6):1255; author reply 1255-6. PubMed ID: 16549509
    [No Abstract]   [Full Text] [Related]  

  • 20. A sixty-five-year-old female with pneumonia, endocarditis and meningitis.
    Fazili T; James O; Wani L
    J Okla State Med Assoc; 2009 Aug; 102(8):269-70. PubMed ID: 19750817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.